Ensysce Biosciences Inc (ENSC) — Cash Flow Reinvestment Rate
Ensysce Biosciences Inc (ENSC) has a Cash Flow Reinvestment Rate of 0.99x as of March 2020, reinvesting $134.62 Million (capex $4.00 plus investments $134.62 Million) from operating cash flow of $136.09 Million. Check ENSC cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ensysce Biosciences Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Ensysce Biosciences Inc across 1 annual periods. Explore Ensysce Biosciences Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Ensysce Biosciences Inc (2019–2019)
Year-by-year capital reinvestment analysis for Ensysce Biosciences Inc. For live market cap and broader valuation context, see ENSC company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 1.08x | $11.85 Million | $10.99 Million | $4.00 | — |